Matches in Nanopublications for { ?s ?p "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP148140.RASYxa5IUKdsPvcLEkEEhLn5pgMwbAfBLecuXTR4B_epM130_assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148140.RASYxa5IUKdsPvcLEkEEhLn5pgMwbAfBLecuXTR4B_epM130_provenance.
- assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP174099.RAtOi14ePeH4chWKFZrhJuYwp00A6JQGWaciMRdMiEloU130_assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174099.RAtOi14ePeH4chWKFZrhJuYwp00A6JQGWaciMRdMiEloU130_provenance.
- NP148139.RA-L63jErs4tfIG_xIyw2YZx4nX5wTh1TRrGHE6aARyCo130_assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148139.RA-L63jErs4tfIG_xIyw2YZx4nX5wTh1TRrGHE6aARyCo130_provenance.
- NP174098.RAyXqvxf2I22eBsFYDw81qic3ez33xaGpGi8yomXHZ0nw130_assertion description "[Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community-dwelling African Americans. Before the age of 65 years, the allele has no discernible impact on cardiac function or mortality. After the age of 70 years, carriers sh]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174098.RAyXqvxf2I22eBsFYDw81qic3ez33xaGpGi8yomXHZ0nw130_provenance.